Muris sends “apologies to Spike Lee”
This article was originally published in The Tan Sheet
Executive Summary
In speech entitled "Do The Right Thing" FTC Chairman Timothy Muris urges cable TV execs to screen weight-loss product ads for obviously deceptive claims. "Our goal is not to require television-network style clearance procedures for weight loss ads," but rather to focus on "the most egregious examples...miracle herbs that claim consumers can eat whatever they want and still lose weight," or "physically implausible" claims, Muris noted at Cable Television Advertising Bureau conference in New York Feb. 11. Vetting would not have to include diets, exercise plans or clinical studies, he added. Noting that "some claim that screening will increase their exposure to tort liability," Muris maintained, "that dog won't hunt. We will send you a list of claims [in the near future] that scientists state are not scientifically feasible"...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.